HCA Healthcare and Grail Collaborate to Advance Comprehensive Cancer Care With Multi-Cancer Early Detection Screening - Illumina (NASDAQ:ILMN), HCA Healthcare (NYSE:HCA)

HCA Healthcare to Offer GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test; HCA Healthcare's Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal HCA Healthcare, Inc.

Related Keywords

Asheville ,North Carolina ,United States ,United Kingdom ,Menlo Park ,Colorado ,Denver ,Washington ,American ,Jeffrey Venstrom ,Chris Ott ,Dax Kurbegov ,Cellular Therapy Network ,Healthcare Inc ,Sarah Cannon Cancer Institute ,Order Of The European Commission ,Drug Administration ,Clinical Programs At Sarah Cannon Cancer Institute ,Cancer Institute ,Healthcare Physician Services ,Illumina Inc ,American Joint Committee On Cancer Staging Manual ,Sarah Cannon Research Institute ,College Of American Pathologists ,American Cancer Society ,Laboratory Test Information ,Healthcare Cancer Institute ,Clinical Laboratory Improvement Amendments ,Multi Cancer Early Detection ,Sarah Cannon ,Support Individuals Who Receive ,American Cancer ,Clinical Programs ,Sarah Cannon Cancer ,Sarah Cannon Transplant ,Interim Measures Order ,American Joint Committee ,Cancer Staging Manual ,Signal Not ,